The content on this site is intended for healthcare professionals only
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Nov 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
9 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
4 Nov 2020
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
2 Nov 2020
Updates in geriatric medical oncology from SIOG meeting
Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...
28 Oct 2020
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
12 Oct 2020
Nivolumab for oesophageal cancer following chemoradiation therapy
Dr Ronan Kelly - Charles A. Sammons Cancer Center, Dallas, USA
25 Sep 2020
Highlights from ESMO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
25 Sep 2020
KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer
Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan
24 Sep 2020
OncoAlert and ecancer weekly roundup for September 14-19, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
23 Sep 2020
ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer
Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan
22 Sep 2020
CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers
Prof Markus Möhler - Universitätsmedizin Mainz, Mainz, Germany
22 Sep 2020
